— Know what they know.
Not Investment Advice

CGON NASDAQ

CG Oncology, Inc. Common stock
1W: -7.1% 1M: -7.6% 3M: +12.1% YTD: +54.6% 1Y: +143.2%
$64.25
-0.34 (-0.53%)
 
Weekly Expected Move ±5.9%
$59 $63 $67 $71 $75
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 32 · $5.7B mcap · 59M float · 2.06% daily turnover · Short 70% of daily vol
Last Earnings 2026-05-08
EPS
$-0.71
▼ Miss -22.4%
Revenue
$1M
▲ Beat +139.1%
Next Earnings 2026-08-07
EPS Estimate
$-0.66
Range: $-0.69 - $-0.63
Revenue Estimate
$333K
9 analysts

Estimate vs Actual

Earnings Surprise History

2/8
EPS Beats
4/8
Revenue Beats
25%
EPS Beat Rate
50%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-21 quarter 2026-06-30 $-0.66 $-0.66 $333,051 $333,051
2026-05-21 annual 2027-12-31 $-2.78 $-2.84 ▼ 0.06 $90,348,879 $87,239,107
2026-05-21 annual 2026-12-31 $-2.72 $-2.74 ▼ 0.02 $11,763,407 $11,051,380
2026-05-21 quarter 2026-12-31 $-0.65 $-0.66 ▼ 0.01 $8,662,053 $8,662,053
2026-05-21 quarter 2026-09-30 $-0.69 $-0.70 ▼ 0.01 $1,287,412 $1,287,412
2026-05-18 quarter 2026-06-30 $-0.66 $-0.66 $334,743 $333,051
2026-05-18 quarter 2026-09-30 $-0.69 $-0.69 $1,289,027 $1,287,412
2026-05-18 annual 2026-12-31 $-2.72 $-2.72 $11,746,764 $11,763,407
2026-05-18 annual 2027-12-31 $-2.78 $-2.78 $90,314,593 $90,348,879
2026-05-18 quarter 2026-12-31 $-0.65 $-0.65 $8,630,822 $8,662,053
2026-05-18 annual 2028-12-31 $-0.21 $-0.13 ▲ 0.08 $467,087,705 $457,844,808
2026-05-18 annual 2029-12-31 $3.22 $3.28 ▲ 0.06 $954,801,750 $960,759,125
2026-05-18 quarter 2027-03-31 $-0.77 $-0.89 ▼ 0.13 $25,000,000 $25,000,000
2026-05-18 quarter 2026-09-30 $-0.68 $-0.69 ▼ 0.01 $1,289,027 $1,289,027
2026-05-18 annual 2027-12-31 $-2.71 $-2.78 ▼ 0.07 $96,957,468 $90,314,593
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms